InvestorNewsBreaks – Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF) to Present Live Virtual Corporate Update Feb. 17
February 11, 2026
This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising. Nevada Organic Phosphate (CSE: NOP) (OTCQB: NOPFF) announced it will present a live virtual corporate update hosted by Existing Agency Inc. on Feb. 17 at 3 p.m. ET. Existing Agency invites current shareholders and interested parties to register for the webinar and participate in a live Q&A session following the presentation. A replay […]
InvestorNewsBreaks – Nevada Organic Phosphate Inc. (CSE: NOP; OTCQB: NOPFF) Reports Initial Assay Results from Murdock Mountain Property in Nevada
February 10, 2026
This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising. Nevada Organic Phosphate (CSE: NOP; OTCQB: NOPFF), a B.C.-based organic sedimentary phosphate explorer, announced continued progress interpreting assay results from the first six drill holes in the Upper Phosphatic Zone at Murdock Mountain, confirming a weighted average grade […]
Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF) Highlights Scalable Organic Fertilizer Supply, Organic Farming Role, at Metals Investor Forum
February 9, 2026
Disseminated on behalf of Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF) and may include paid advertising. Nevada Organic Phosphate (CSE: NOP) (OTCQB: NOPFF), a B.C.-based leader in organic sedimentary phosphate exploration, participated in the Metals Investor Forum in January 2026, where it highlighted its position as a significant potential producer of raw, organic, direct-ship […]
InvestorNewsBreaks – DitGold’s DITAU Token to Begin Spot Trading on Biconomy
February 3, 2026
DitGold announced that its native DITAU token will be listed for spot trading on Biconomy, with the DITAU/USDT trading pair scheduled to go live on Feb. 4, 2026, at 12:00 UTC. The listing expands market access for DITAU and supports DitGold’s strategy to build a decentralized ecosystem centered on data as a store of value. […]
Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF) Positive Assay Results Point to Organic Fertilizer Certification
January 26, 2026
Disseminated on behalf of Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF) and may include paid advertising. Nevada Organic Phosphate (CSE: NOP) (OTCQB: NOPFF), a Canadian based leader in organic sedimentary phosphate exploration, reported assay results on January 12 that address one of the central questions facing its Murdock Mountain project in northeast Nevada: whether […]
InvestorNewsBreaks – Nevada Organic Phosphate Inc. CSE: NOP; OTCQB: NOPFF) Accelerates Expiry of 2025 Warrants
January 22, 2026
This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising. Nevada Organic Phosphate (CSE: NOP; OTCQB: NOPFF), a British Columbia-based organic sedimentary phosphate exploration company, announced it has elected to accelerate the expiry of 13,968,100 outstanding common share purchase warrants issued under financings completed between Feb. 21 and July 22, 2025, which, if fully exercised, could […]
InvestorNewsBreaks – Oncotelic Therapeutics Inc.’s (OTLC) Deciparticle(TM) Platform Expands Possibilities in Immunology and Oncology
January 21, 2026
Oncotelic Therapeutics (OTCQB: OTLC) is rapidly emerging in next-generation drug delivery, with a scalable nanotechnology platform that can transform the paradigms of immunology and oncology treatments. “Leveraging Sapu Nano, the company’s clinical-stage nanomedicine, it unveiled new data at the 2025 San Antonio Breast Cancer Symposium (‘SABCS’), highlighting that its Deciparticle(TM) platform can package even the […]
Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) Finds Critical Market Opportunity Addressing Rare Earth Mining Supply Chain Challenges
January 13, 2026
Disseminated on behalf of Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) and may include paid advertising. Rare earth minerals have made news headlines in recent years as part of the justification for shifts in international economic policies. This includes trade disputes with China (https://ibn.fm/hgeOD) and the Russia-Ukraine conflict (https://ibn.fm/M0je3), as well as U.S. interests in […]
InvestorNewsBreaks – Nevada Organic Phosphate Inc. (CSE: NOP; OTCQB: NOPFF) Confirms Murdock Mountain Heavy Metal Assays Well Below Organic Fertilizer Limits
January 12, 2026
This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising. Nevada Organic Phosphate (CSE: NOP; OTCQB: NOPFF) reported that heavy metal contaminant assays from the Upper Phosphatic Zone at its Murdock Mountain project returned results well below maximum allowable thresholds under AAPFCO’s SUIP #25 standards, which are widely […]
InvestorNewsBreaks – Oncotelic Therapeutics Inc. (OTLC) Advances Nanoparticle Drug Delivery, Prepares First-in-Human Study of IV Everolimus
January 9, 2026
Oncotelic Therapeutics (OTCQB: OTLC) is positioned at the heart of the evolving landscape of pharmaceutical innovation, applying ultra-small carrier technologies to elevate existing cancer therapies. “The company is pioneering how nanotechnology can enhance bioavailability, precision targeting and therapeutic performance of anticancer compounds,” reads a recent article. “The advantages of nanoparticle delivery in pharma are significant… […]
InvestorNewsBreaks – Estrella Immunopharma, Inc. (NASDAQ: ESLA, ESLAW) Closes $8.0 Million Registered Direct Offering
January 7, 2026
Estrella Immunopharma (NASDAQ: ESLA, ESLAW) announced the closing of its previously announced registered direct offering with a single healthcare-focused institutional investor, generating aggregate gross proceeds of approximately $8.0 million. The offering included the issuance of 4,063,290 shares of common stock and 1,000,000 pre-funded warrants, together with a concurrent private placement of common warrants to purchase […]
InvestorNewsBreaks – Nevada Organic Phosphate Inc. (CSE: NOP; OTCQB: NOPFF) Reports Strong Final P₂O₅ Assay Results From 2025 Drill Program
January 5, 2026
This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising. Nevada Organic Phosphate (CSE: NOP; OTCQB: NOPFF), a B.C.-based company focused on organic sedimentary phosphate exploration, announced that final P₂O₅ assay results from its 2025 drill program at the Murdock Mountain Property in Elko County, Nevada, continue to […]
InvestorNewsBreaks – Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF) Begins Trading on OTCQB Venture Market
December 29, 2025
This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising. Nevada Organic Phosphate (CSE: NOP) (OTCQB: NOPFF) a B.C.-based organic sedimentary phosphate exploration company, announced that its common shares have commenced trading on the OTCQB Venture Market at the market open on Dec. 29, 2025, under the symbol “NOPFF,” further to its Dec. 8, 2025, […]
Oncotelic Therapeutics Inc. (OTLC) Unveils Breakthrough Nanomedicine Platform, Expands Everolimus (Afinitor(R)) Pipeline
December 23, 2025
Oncotelic Therapeutics (OTCQB: OTLC) is rapidly emerging as a key player in next-generation drug delivery, with a scalable nanotechnology platform that can transform the paradigms of immunology and oncology treatments. Leveraging Sapu Nano, the company’s clinical-stage nanomedicine, it unveiled new data at the 2025 San Antonio Breast Cancer Symposium (“SABCS”), highlighting that its Deciparticle(TM) platform […]
InvestorNewsBreaks – Nevada Organic Phosphate Inc. (CSE: NOP) Reports Initial Assay Results From Murdock Mountain Property in Nevada
December 22, 2025
This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising. Nevada Organic Phosphate (CSE: NOP) announced the first assay results from its wholly owned Murdock Mountain Property in Elko County, Nevada, marking an important milestone in the advancement of the project. Initial results from three drill holes targeting the Upper Phosphatic Zone returned phosphate […]
InvestorNewsBreaks – TransCode Therapeutics, Inc. (NASDAQ: RNAZ) Appoints Jack E. Stover to Board of Directors
December 22, 2025
TransCode Therapeutics (NASDAQ: RNAZ) announced the appointment of Jack E. Stover to its Board of Directors, where he will serve on the Audit Committee and the Nominating Committee, as Dr. Magda Marquet steps down from the Audit Committee. Mr. Stover brings more than 30 years of executive leadership experience across public and private life sciences companies, with a background spanning […]
Oncotelic Therapeutics Inc. (OTLC) Leverages Nanoparticles to Re-Imagine Drug Delivery in Oncology
December 17, 2025
In the evolving landscape of pharmaceutical innovation, nanoparticles are rapidly transforming how we think about drug delivery, and Oncotelic Therapeutics (OTCQB: OTLC) is placing itself at the heart of that transformation by applying ultra-small carrier technologies to elevate existing cancer therapies. The company is pioneering how nanotechnology can enhance bioavailability, precision targeting and therapeutic performance […]
Strategic Metals and Nevada’s Mining Renaissance: Why Fairchild Gold Corp. (TSX.V: FAIR) (OTCID: FCHDF) Is Positioned for America’s Next Resource Cycle
December 16, 2025
Disseminated on behalf of Fairchild Gold Corp. (TSX.V: FAIR) (OTCID: FCHDF) and may include paid advertising. America’s resource landscape is undergoing one of its most significant shifts in decades. Global copper inventories are tightening, new mine development is failing to keep pace with demand from artificial intelligence infrastructure and electrification, and the U.S. is rethinking […]
InvestorNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Collaborates on Peer-Reviewed Biomarker Study in International Journal of Molecular Sciences
December 15, 2025
Oncotelic Therapeutics (OTCQB: OTLC), in collaboration with the Brush and Key Foundation, announced the publication of a peer-reviewed research article in the International Journal of Molecular Sciences titled “Comparative Tumor Microenvironment Analysis for HCC and PDAC Using KMplotter,” which analyzes the prognostic significance of biomarkers DNMT3A and GMPS across hepatocellular carcinoma and pancreatic ductal adenocarcinoma. […]
InvestorNewsBreaks – Nevada Organic Phosphate Inc. (CSE: NOP) Secures Full Ownership of Murdock Mountain Project and Eliminates NSR
December 15, 2025
This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising. Nevada Organic Phosphate (CSE: NOP) a B.C.-based company focused on organic sedimentary phosphate exploration, announced the signing of an agreement that results in 100% ownership of its Murdock Mountain Project and the elimination of certain net smelter return […]
InvestorNewsBreaks – Nevada Organic Phosphate Inc. (CSE: NOP) Applies for OTCQB Listing to Expand U.S. Investor Reach
December 8, 2025
This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising. Nevada Organic Phosphate (CSE: NOP) announced it has initiated the application process to list its common shares on the OTCQB Venture Market in the United States. The OTCQB is designed for early-stage and entrepreneurial companies that meet ongoing […]
InvestorNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) JV Sapu Nano Presents Data Showing Deciparticle Platform Supports Broad Hydrophobic Drug Formulation
December 2, 2025
Oncotelic Therapeutics (OTCQB: OTLC) said its 45%-owned joint venture, Sapu Nano, reported new data at the 2025 San Antonio Breast Cancer Symposium showing that its Deciparticle(TM) nanomedicine platform can consistently formulate structurally diverse hydrophobic therapeutics—including macrolide mTOR inhibitors, cyclic and linear peptides, ascomycin macrolactams and polyketides—into sub-20 nm nanoparticles suitable for IV delivery. The Company […]
Nevada Organic Phosphate Inc. (CSE: NOP) Is ‘One to Watch’
December 2, 2025
Disseminated on behalf of Nevada Organic Phosphate Inc. (CSE: NOP) and may include paid advertising. Nevada Organic Phosphate (CSE: NOP) is a junior exploration company focused on exploring and advancing an organic sedimentary raw rock phosphate project in northeast Nevada. The company’s business model centers on developing a rare, direct-application phosphate product that aligns with the […]
InvestorNewsBreaks – Nevada Organic Phosphate Inc. (CSE: NOP) Releases Updated Murdock Mountain Project Factsheet
December 1, 2025
This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising. Nevada Organic Phosphate (CSE: NOP) published an updated Project Factsheet featuring new graphics that highlight the scale and consistency of the Murdock Mountain Upper Phosphatic Zone, with drilling intersecting the Meade Peak stratigraphy as predicted by the company’s […]
InvestorNewsBreaks – Nevada Organic Phosphate Inc. (CSE: NOP) Reports Additional Positive Drill Results from MM25-6 at Murdock Mountain
November 19, 2025
This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising. Nevada Organic Phosphate (CSE: NOP), a B.C.-based leader in organic sedimentary phosphate exploration, reported further encouraging observations from drill hole MM25-6 at its wholly owned Murdock Mountain Property in Elko County, Nevada. The hole intersected 37.3 metres of […]
InvestorNewsBreaks – TransCode Therapeutics, Inc. (NASDAQ: RNAZ) Appoints Dr. Michel Janicot as Senior Development Officer
November 17, 2025
TransCode Therapeutics (NASDAQ: RNAZ) appointed Dr. Michel Janicot as consultant Senior Development Officer, adding more than 35 years of global oncology drug-development experience to support the advancement of TTX-MC138 and Seviprotimut-L. Dr. Janicot, founder of JMi ONConsulting and former senior leader at Rhône-Poulenc Rorer and Janssen, brings deep expertise in RNA biology, preclinical strategy, translational […]
ROTH to Host 14th Annual Technology Conference at the Hard Rock Hotel in New York City
November 12, 2025
NEW YORK, Nov. 12, 2025 (GLOBE NEWSWIRE) — via IBN — Roth Capital Partners, LLC (“ROTH”), www.roth.com, is pleased to announce it will host the 14th Annual Roth Technology Conference on November 18-19, 2025, at the Hard Rock Hotel, 159 W 48th St, New York, NY 10036. The conference will provide pre-qualified institutional investors with the opportunity to […]
InvestorNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) and Sapu Bioscience Publish Landmark Review Defining Sub-15 nm Nanoparticles as New Frontier in Drug Delivery
November 11, 2025
Oncotelic Therapeutics (OTCQB: OTLC), and joint venture partner Sapu Bioscience today announced the publication of their review article, “Sub-15 nm Nanoparticles for Drug Delivery: Emerging Frontiers and Therapeutic Potential,” in the International Journal of Molecular Sciences (IJMS 2025, 26, 10842; https://doi.org/10.3390/ijms262210842). Authored by Dr. Tapas De, Vuong Trieu, Scott Myers, Sanjive Qazi, Saran Saund, and […]
NetworkNewsAudio Announces Audio Press Release (APR) on Transforming Once-Marginal Drugs into Category-Changing Assets
October 31, 2025
AUSTIN, Texas, Oct. 31, 2025 (GLOBE NEWSWIRE) — via IBN – NetworkNewsAudio announces the Audio Press Release (APR) title “Nanomedicine Breakthrough Technology Redefining Drug Delivery, Bioavailability in Oncology,” featuring Oncotelic Therapeutics Inc. (OTCQB: OTLC). To hear the NetworkNewsAudio version, visit https://nnw.fm/kSRbS To read the original editorial, visit https://nnw.fm/rbsvJ Within oncology, nanocarrier delivery has accelerated following regulatory validations such as FDA approvals of nanoparticle-formulated chemotherapies […]
Soligenix Inc. (NASDAQ: SNGX) Research Highlights Breakthrough in High-Temperature Vaccine Stability
October 28, 2025
Current vaccines for Ebola and similar filoviruses face a major deployment barrier: Most require storage between 2°C and 8°C throughout transport, making them vulnerable to spoilage when exposed to the high ambient heat common in many outbreak regions (https://ibn.fm/MZWfk). Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company specializing in biodefense and rare disease vaccines, has published […]
Fairchild Gold (TSX.V: FAIR) Announces Major Asset Acquisition, High-Profile Advisory Board Appointments
October 24, 2025
This article has been disseminated on behalf of Fairchild Gold and may include paid advertising. Fairchild (TSX.V: FAIR) is positioning itself as a significant player in Nevada’s prolific mining landscape with the announcement of its acquisition of the Golden Arrow Project, an advanced-stage gold and silver property located along the highly prospective Walker Lane Shear Zone (ibn.fm/5ZD9A). […]
Nanomedicine’s Next Leap: Why Particle Size Matters in Cancer Drug Delivery
October 21, 2025
Oncotelic Therapeutics Inc. (OTCQB: OTLC) is advancing precision nanomedicine with its proprietary Deciparticle(TM) platform, beginning human trials for Sapu003, a 20nm nanoparticle formulation of Everolimus (Afinitor(R)). This scientific briefing explores why particle size is critical to drug efficacy, how Oncotelic’s technology enhances tumor targeting, and how its rapid IND platform accelerates clinical development across multiple […]
West Vault Mining Inc. (TSX.V: WVM) (OTCQX: WVMDF): Gold Exposure by Holding Nevada Gold Reserves in the Ground
October 17, 2025
This article has been disseminated on behalf of West Vault Mining and may include paid advertising. A Safe Haven Reasserts Itself Gold’s reputation as a hedge against inflation, weakening currencies and market volatility has rarely felt more relevant. Global investors, from central banks to individuals, continue accumulating the metal as protection against persistent inflation, geopolitical conflict, and […]
InvestorNewsBreaks – PowerBank Corporation (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: 103) Secures 20 MW Solar and Storage Project Portfolio with New York State DMNA
October 14, 2025
This article has been disseminated on behalf of PowerBank and may include paid advertising. Disseminated on behalf of PowerBank Corporation PowerBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: 103) announced it has executed lease and power purchase agreements with the New York State Division of Military and Naval Affairs (DMNA) to develop a 20 MW DC portfolio […]
InvestorNewsBreaks – TransCode Therapeutics, Inc. (NASDAQ: RNAZ) Completes Phase 1a Trial of TTX-MC138, Advancing to Phase 2 Evaluation
October 14, 2025
TransCode Therapeutics (NASDAQ: RNAZ) announced completion of its Phase 1a clinical trial of TTX-MC138, an investigational inhibitor of microRNA-10b, achieving its primary safety endpoint and establishing a recommended Phase 2 dose. Sixteen patients were treated with no significant safety events or dose-limiting toxicities observed, and 44% achieved stable disease lasting four months or longer. The […]
InvestorNewsBreaks – TransCode Therapeutics, Inc. (NASDAQ: RNAZ) Acquires Polynoma, Secures $25 Million Investment from CK Life Sciences to Advance Phase 2 Trial of TTX-MC138
October 8, 2025
TransCode Therapeutics (NASDAQ: RNAZ) announced it has entered into a definitive agreement to acquire Polynoma LLC, a privately held immuno-oncology company developing seviprotimut-L, a late-stage polyvalent shed antigen vaccine for the adjuvant treatment of stage IIB and IIC melanoma. Concurrent with the acquisition, TransCode secured a $25 million investment from CK Life Sciences Int’l (Holdings) […]
Oncotelic Therapeutics Inc.’s (OTLC) Sapu003: Injectable Everolimus (Afinitor(R)) to Begin Clinical Trials, Aiming to Boost Drug Bioavailability
October 8, 2025
Oncotelic Therapeutics (OTCQB: OTLC) is a clinical-stage biopharmaceutical company advancing a diversified pipeline spanning oncology, immunotherapy, neurodegeneration, and rare diseases. In a recent interview on the BioMedWire podcast, Chairman and CEO Dr. Vuong Trieu emphasized the company’s unique model: focusing on de-risked, late-stage assets and accelerating their development through regulatory pathways designed for speed and […]
ROTH to Host 4th Annual Healthcare Opportunities Conference on October 9 in New York City
October 1, 2025
NEW YORK, Oct. 01, 2025 (GLOBE NEWSWIRE) — via IBN — ROTH Capital Partners, LLC (“ROTH”), www.roth.com, is pleased to announce it will host the 4th Annual ROTH Healthcare Opportunities Conference on October 9, 2025, at the Metropolitan Club, New York City, NY. The Annual ROTH Healthcare Opportunities Conference will once again bring together C-suite executives from innovative public […]
FAIRCHILD TO ACQUIRE 100% OF ADVANCED STAGE GOLDEN ARROW PROJECT FURTHER EXPANDING ITS FOOTPRINT ON THE WALKER LANE SHEAR ZONE REGION OF NEVADA
October 1, 2025
Vancouver, British Columbia , Sept. 29, 2025 (GLOBE NEWSWIRE) — via IBN – Fairchild Gold Corp. (“Fairchild” or the “Company”) (TSXV: FAIR), is pleased to announce that it has entered into a Memorandum of Understanding (the “MOU”) dated September 26, 2025 with Emergent Metals Corp. (TSXV: EMR) (“Emergent”), an arm’s length party, to acquire a 100% […]
West Vault Mining Inc. (TSX.V: WVM) (OTCQX: WVMDF) Poised to Unlock Value Through Strong Gold Market Fundamentals
September 30, 2025
Maximizing Gold Leverage While Minimizing Risk Gold has surged to new record highs – recently surpassing $3,780 per ounce – as investors worldwide turn to the metal’s proven role as a hedge against inflation, currency weakness, and financial-market volatility (ibn.fm/29CUk). With expectations of rate cuts, central bank demand, and softer global growth, analysts see further […]